Australia markets open in 4 hours 55 minutes

Visioneering Technologies, Inc. (VTI.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.10000.0000 (0.00%)
At close: 12:26PM AEST

Visioneering Technologies, Inc.

30 Mansell Court
Suite 215
Alpharetta, GA 30076
United States
844-884-5367
https://www.vtivision.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Richard A. GriffinFounder & Medical AdviserN/AN/AN/A
Ms. Layna L. MendlingerGlobal Head of MarketingN/AN/AN/A
Ms. Leanne Ralph AAICD, ACIS, BBusCompany SecretaryN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Corporate governance

Visioneering Technologies, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.